Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
US: AMGN

Amgen Inc.

Healthcare
$442.24 +0.00 (+0.00%) as of 2026-08-26 08:02 UTC
Market Cap$238.3B
Volume1.97M

Amgen Inc. (AMGN) is a $238.3B healthcare company trading at $442.24 (+0.0% today). Figures from SEC EDGAR and market feeds; updated 2026-08-26 08:02 UTC.

52-Week Range
Low $320.53High $447.03

What Amgen Inc. does

Amgen is a biotechnology company that discovers, develops, manufactures and delivers medicines to treat serious diseases, operating in one segment focused on human therapeutics. The company has a presence in approximately 100 countries and sells its products through pharmaceutical wholesale distributors in the United States and through healthcare providers and distributors internationally, with the United States representing its largest market.

Summarized from Amgen Inc.’s SEC filings · Read the filing ↗

Key facts

Quote
Price$442.24
Change (1D)+0.00 (+0.00%)
Market cap$238.3B
Volume1.97M shares
52-week range$320.53 – $447.03
Returns
52-week return+38.0%

Revenue, margins & earnings

FY2021 Net income: $5.89BFY2021 Taxes & interest: $1.75BFY2021 Operating costs: $18.3B$26.0BFY2021FY2022 Net income: $6.55BFY2022 Taxes & interest: $3.01BFY2022 Operating costs: $16.8B$26.3BFY2022FY2023 Net income: $6.72BFY2023 Taxes & interest: $1.18BFY2023 Operating costs: $20.3B$28.2BFY2023FY2024 Net income: $4.09BFY2024 Taxes & interest: $3.17BFY2024 Operating costs: $26.2B$33.4BFY2024FY2025 Net income: $7.71BFY2025 Taxes & interest: $1.37BFY2025 Operating costs: $27.7B$36.8BFY2025
  • Net income
  • Taxes & interest
  • Operating costs
Annual revenue; bands show net, operating margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-08-13
  • 2026-08-13Khosla RachnaSVP, Business DevelopmentM1,252$203.6K
  • 2026-08-13Khosla RachnaSVP, Business DevelopmentSELL-2,000$825.1K
  • 2026-08-13Khosla RachnaSVP, Business DevelopmentSELL-1,252$521.4K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Amgen Inc. do?

Amgen is a biotechnology company that discovers, develops, manufactures and delivers medicines to treat serious diseases, operating in one segment focused on human therapeutics.

What is AMGN's valuation?

AMGN trades at $442.24, as of 2026-08-26.

When did AMGN last file with the SEC?

Amgen Inc.'s most recent SEC filing on record is a 10-Q filed 2026-08-05. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-08-26 08:02 UTC. This page is also available as JSON at /api/data?ticker=AMGN and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for AMGN and 5,000+ tickers.

Create a free account — keep AMGN
For your agent
GET /api/data?ticker=AMGN

This page as JSON via rel="alternate" · REST API docs · MCP server (53 tools) · llms.txt